212 results on '"Lund, Bendik"'
Search Results
2. The Norwegian Childhood Cancer Biobank
3. Intelligence and executive function are associated with age at insult, time post-insult, and disability following chronic pediatric acquired brain injury
4. No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study
5. Health-related quality of life and psychological distress in young adult survivors of childhood cancer and their association with treatment, education, and demographic factors
6. Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy
7. NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia
8. Bereaved parents' quality of life : resilience and professional support
9. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial
10. Supplementary Figure 3 from Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome
11. Supplementary figure 2 from Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome
12. Supplementary figure 1 from Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome
13. Supplementary Table 1 from Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome
14. Individualized 6‐mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial
15. Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration
16. Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype-genotype study
17. Characteristics of white blood cell count in acute lymphoblastic leukemia : A COST LEGEND phenotype-genotype study
18. Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype-genotype study
19. Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype–genotype study
20. Bereaved parents’ quality of life: resilience and professional support
21. Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2
22. The Norwegian childhood cancer biobank
23. Relapse risk following truncation of PEG-asparaginase in childhood acute lymphoblastic leukemia
24. No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia:a NOPHO ALL2008 sub-study
25. TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia
26. The Norwegian childhood cancer biobank.
27. DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysis
28. Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia
29. Host genome variations and risk of infections during induction treatment for childhood acute lymphoblastic leukaemia
30. Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome
31. Effects of germline variants in DHFR and FPGS on methotrexate metabolism and relapse of leukemia
32. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia : Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age
33. Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocols
34. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia:Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age
35. TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia
36. WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder
37. Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia
38. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia
39. Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocols
40. Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia
41. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age
42. Intensive Chemotherapy for High-Risk ALL in Children - the Nordic Collaborative Approach
43. Value of Flow Cytometry for MRD-Based Relapse Prediction in B-Cell Precursor Acute Lymphoblastic Leukemia in a Multi-Center Setting
44. Asparaginase-Associated Pancreatitis in ALL: Results from the NOPHO ALL2008 Treatment of Patients 1-45 Years
45. Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy
46. Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia : The NOPHO ALL2008 experience
47. Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008
48. Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia:The NOPHO ALL2008 experience
49. Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities:A NOPHO ALL2008 Randomized Study
50. MOESM1 of Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.